Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
Year: 2021
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Authors: Bo Xu, Shengxian Tu, Lei Song, Zening Jin, Bo Yu, Guosheng Fu, Yujie Zhou, Jian’an Wang, Yundai Chen, Jun Pu, Lianglong Chen, Xinkai Qu, Junqing Yang, Xuebo Liu, Lijun Guo, Chengxing Shen, Yaojun Zhang, Qi Zhang, Hongwei Pan, Xiaogang Fu, Jian Liu, Yanyan Zhao, Javier Escaned, Yang Wang, William F Fearon, Kefei Dou, Ajay J Kirtane, Yongjian Wu, Patrick W Serruys, Weixian Yang, William Wijns, Changdong Guan, Martin B Leon, Shubin Qiao, Gregg W Stone
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Fu Wai Hospital, Shanghai Jiao Tong University, Capital Medical University, Beijing Tian Tan Hospital, Harbin Medical University, Second Affiliated Hospital of Harbin Medical University, Sir Run Run Shaw Hospital, Zhejiang University, Beijing Anzhen Hospital, Second Affiliated Hospital of Zhejiang University, Chinese PLA General Hospital, Renji Hospital, Union Hospital, Fudan University, Huadong Hospital, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Tongji University, Peking University Third Hospital, Shanghai Sixth People's Hospital, Shanghai East Hospital, Hunan Provincial People's Hospital, Peking University People's Hospital, Universidad Complutense de Madrid, Hospital Clínico San Carlos, VA Palo Alto Health Care System, Stanford Cardiovascular Institute, Stanford University, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, Cardiovascular Research Foundation, Columbia University, Ollscoil na Gaillimhe – University of Galway, Imperial College London, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G2806921574
OpenAlex ID: W3209670581
